Literature DB >> 17885620

Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3).

Charles K Allerston1, Makiko Shimizu, Masaki Fujieda, Elizabeth A Shephard, Hiroshi Yamazaki, Ian R Phillips.   

Abstract

OBJECTIVES: Flavin-containing monooxygenase 3 (FMO3) is involved in the metabolism of foreign chemicals, including therapeutic drugs, and thus mediates interactions between humans and their chemical environment. Loss-of-function mutations in the gene cause the inherited disorder trimethylaminuria, or fish-odour syndrome. The objective was to gain insights into the evolutionary history of FMO3.
METHODS: Genetic diversity within FMO3 was characterized by sequencing 6.3 kb of genomic DNA, encompassing the entire coding sequence, some intronic and 3'-untranslated region, and 3.4 kb of 5'-flanking sequence, in 23 potential trimethylaminuric Japanese, and the same 3.4 kb 5'-flanking region in 45 unaffected Japanese. Mutational relationships among haplotypes were inferred from a reduced-median network. The time depth of the variation and ages of individual mutations were estimated by maximum-likelihood coalescent analysis. Test statistics were used to investigate whether the variation is compatible with neutral evolution.
RESULTS: Sixteen single-nucleotide polymorphisms (SNPs) were identified, which segregated as seven distinct haplotypes. Estimated ages of the mutations indicate that almost all predated migration out of Africa. Analysis of the heterozygosity of FMO3 SNPs indicates that genetic differentiation among continental populations is low (FST=0.050). Test statistics, based on allele-frequency spectrum, number and diversity of haplotypes, linkage disequilibrium and interspecific sequence comparisons, showed a significant departure from neutral expectations, because of an excess of intermediate-frequency SNPs and haplotypes, a ragged pairwise mismatch distribution and an excess of replacement polymorphisms.
CONCLUSION: The results provide evidence that FMO3 has been the subject of balancing selection. Finally, we identify mutations that are potential targets for selection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885620     DOI: 10.1097/FPC.0b013e328256b198

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  12 in total

1.  Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.

Authors:  Makiko Shimizu; Charles K Allerston; Elizabeth A Shephard; Hiroshi Yamazaki; Ian R Phillips
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

2.  Molecular phylogeny, long-term evolution, and functional divergence of flavin-containing monooxygenases.

Authors:  Da Cheng Hao; Shi Lin Chen; Jun Mu; Pei Gen Xiao
Journal:  Genetica       Date:  2009-07-05       Impact factor: 1.082

3.  A signature of balancing selection in the region upstream to the human UGT2B4 gene and implications for breast cancer risk.

Authors:  Chang Sun; Dezheng Huo; Catherine Southard; Barbara Nemesure; Anselm Hennis; M Cristina Leske; Suh-Yuh Wu; David B Witonsky; Olufunmilayo I Olopade; Anna Di Rienzo
Journal:  Hum Genet       Date:  2011-06-10       Impact factor: 4.132

4.  Developmental variations in metabolic capacity of flavin-containing mono-oxygenase 3 in childhood.

Authors:  Makiko Shimizu; Travis Denton; Marie Kozono; John R Cashman; J Steven Leeder; Hiroshi Yamazaki
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

5.  Inter-individual variation in flavin-containing monooxygenase 3 in livers from Japanese: correlation with hepatic transcription factors.

Authors:  Satomi Nagashima; Makiko Shimizu; Hiroshi Yano; Norie Murayama; Toshio Kumai; Shinichi Kobayashi; F Peter Guengerich; Hiroshi Yamazaki
Journal:  Drug Metab Pharmacokinet       Date:  2009       Impact factor: 3.614

6.  Role of flavin-containing monooxygenase in oxidative metabolism of voriconazole by human liver microsomes.

Authors:  Souzan B Yanni; Pieter P Annaert; Patrick Augustijns; Arlene Bridges; Yan Gao; Daniel K Benjamin; Dhiren R Thakker
Journal:  Drug Metab Dispos       Date:  2008-03-24       Impact factor: 3.922

7.  The emergence of human-evolutionary medical genomics.

Authors:  Bernard J Crespi
Journal:  Evol Appl       Date:  2010-10-12       Impact factor: 5.183

8.  Molecular population genetics of human CYP3A locus: signatures of positive selection and implications for evolutionary environmental medicine.

Authors:  Xiaoping Chen; Haijian Wang; Gangqiao Zhou; Xiumei Zhang; Xiaojia Dong; Lianteng Zhi; Li Jin; Fuchu He
Journal:  Environ Health Perspect       Date:  2009-06-18       Impact factor: 9.031

9.  Intriguing balancing selection on the intron 5 region of LMBR1 in human population.

Authors:  Fang He; Dong-Dong Wu; Qing-Peng Kong; Ya-Ping Zhang
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

10.  Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients.

Authors:  Cassianne Robinson-Cohen; Richard Newitt; Danny D Shen; Allan E Rettie; Bryan R Kestenbaum; Jonathan Himmelfarb; Catherine K Yeung
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.